Signify Competitors

Delisted . USA . 
Stock . Signify Health
SGFYDelisted Stock  USD 30.49  0.00  0.00%   
Signify Health competes with Evolent Health, CareMax, Certara, National Research, and Definitive Healthcare; as well as few others. The company conducts business under Healthcare sector and is part of Health Information Services industry. Analyzing Signify Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Signify Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Signify Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
30.4930.4930.49
Details
Intrinsic
Valuation
LowRealHigh
25.4425.4433.54
Details
Naive
Forecast
LowNextHigh
31.2831.2831.28
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
28.2129.5830.95
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Signify Health. Your research has to be compared to or analyzed against Signify Health's peers to derive any actionable benefits. When done correctly, Signify Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Signify Health.

Signify Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Signify Health and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Signify and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Signify Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
HSTM
+ 0.74
MDRX
CMAX
+ 0.7
EVH
CERT
+ 0.67
CMAX
HSTM
+ 0.67
RCM
CERT
+ 0.6
EVH
CPSI
+ 0.6
CERT
  
High negative correlations   
HSTM
- 0.86
EVH
RCM
- 0.86
EVH
NRC
- 0.74
RCM
RCM
- 0.71
CMAX
RCM
- 0.68
CERT
MDRX
- 0.6
EVH

Risk-Adjusted Indicators

There is a big difference between Signify Stock performing well and Signify Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Signify Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EVH  3.24 (1.18) 0.00 (0.83) 0.00 
 0.00 
 5.49 
(5.92)
 51.11 
AGTI  2.06 (0.06)(0.04) 0.02  2.87 
(1.81)
 4.03 
(4.45)
 10.75 
CMAX  6.54 (2.15) 0.00 (3.62) 0.00 
 0.00 
 12.64 
(17.39)
 80.24 
CERT  1.95 (0.51) 0.00 (0.13) 0.00 
 0.00 
 5.82 
(4.01)
 15.96 
RCM  0.10  0.02 (0.61) 1.29  0.00 
(0.15)
 0.29 
(0.21)
 0.64 
MDRX  1.27  0.06 (0.01) 0.28  2.08 
(1.14)
 2.58 
(3.07)
 8.73 
NRC  1.96 (0.36) 0.00 (0.09) 0.00 
 0.00 
 3.79 
(4.72)
 13.17 
CPSI  1.50 (0.20) 0.00 (0.49) 0.00 
 0.00 
 2.85 
(3.01)
 14.25 
DH  2.06 (0.16)(0.03) 0.03  2.42 
(2.26)
 4.37 
(4.00)
 13.20 
HSTM  1.21  0.07  0.04  0.19  1.31 
(1.32)
 2.33 
(2.00)
 10.49 
All Fundamental Data

Signify Health Competitive Analysis

The better you understand Signify Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Signify Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Signify Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SGFY EVH AGTI CMAX CERT RCM MDRX NRC CPSI DH
 0.00 
 30.49 
Signify
 2.49 
 12.93 
Evolent
 1.26 
 16.89 
Agiliti
 26.32 
 0.42 
CareMax
 3.11 
 11.27 
Certara
 0.07 
 14.31 
RCM
 0.15 
 13.33 
Veradigm
 0.31 
 19.48 
National
 1.20 
 25.33 
CPSI
 0.43 
 4.66 
Definitive
Market Volatility
(90 Days Market Risk)
Very steady
Somewhat reliable
Very steady
Abnormally volatile
Not too volatile
Very steady
Very steady
Not too volatile
Very steady
Somewhat reliable
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Good
Very Weak
Very Weak
Very Weak
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Below Average
Dangerous
Very High
Below Average
Dangerous
Dangerous
Low
Dangerous
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Not Available
Hold
Buy
Not Available
Not Available
Buy
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Sell
Not Rated
Strong Sell
Hold
Not Rated
Not Rated
Strong Sell
Not Rated
Hold
Current Ratio
5.23
1.03
1.68
6.06
3.51
1.56
3.23
1.31
1.78
3.32
Net Asset
1.74 B
2.68 B
2.46 B
623.3 M
1.56 B
4.96 B
2.43 B
122.44 M
430.96 M
1.83 B
Profit Margin
-0.72
-0.0293
-0.0165
-1.0
-0.0834
-0.0248
0.0397
0.19
-0.13
-1.42
EBITDA
(549.94 M)
(24.79 M)
230.24 M
(590.46 M)
23.84 M
426.2 M
362.9 M
45.98 M
14.02 M
(241.23 M)
Operating Margin
0.0974
-0.0259
0.0704
-0.0994
0.0674
0.0378
0.17
0.22
-0.0411
0.0126
Current Valuation
6.66 B
2.06 B
3.87 B
498.96 M
1.83 B
8.19 B
395.97 M
511.24 M
279.71 M
492.45 M
Price To Book
10.25
1.47
1.45
0.4
1.67
2.15
0.57
13.32
0.59
1.07
Retained Earnings
N/A
(719.19 M)
(33.7 M)
(720.94 M)
(116.23 M)
(136.7 M)
767.56 M
(30.53 M)
53.92 M
(227.45 M)
Current Asset
N/A
184.46 M
N/A
N/A
N/A
254.39 M
538.35 M
27.6 M
74.56 M
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.24
2.46
N/A
Beta
0.36
1.59
1.59
0.68
1.51
0.84
0.7
0.53
0.69
1.34
Number Of Employees
2.1 K
4.7 K
5.8 K
1.45 K
1.34 K
29.4 K
8 K
435
29
950
Shares Outstanding
179.05 M
115.03 M
136.08 M
3.81 M
160.98 M
422.39 M
109.26 M
23.48 M
14.55 M
115.52 M
Cash Flow From Operations
98 K
142.58 M
169.82 M
(46.91 M)
82.75 M
340.1 M
(75.4 M)
38.11 M
15.48 M
41.19 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0246
N/A
N/A
Total Debt
333.1 M
644.8 M
1.17 B
491.93 M
298.19 M
1.74 B
434.5 M
38.96 M
145.18 M
267.93 M
Return On Equity
-0.11
-0.0578
-0.0203
-3.28
-0.0295
-0.022
0.0893
0.59
-0.22
-0.55
Z Score
15.6
N/A
N/A
N/A
N/A
N/A
2.59
N/A
1.7
N/A
Return On Asset
0.0254
0.0073
0.0177
-0.11
0.0059
0.0235
0.0216
0.19
-0.0063
-0.0076
Number Of Shares Shorted
15.71 M
10.82 M
1.09 M
463.58 K
5.36 M
10.81 M
7.46 M
341.73 K
461.03 K
2.72 M
Book Value Per Share
3.51
9.03
6.95
-38.73
6.55
6.66
10.77
1.48
13.14
4.39
Current Liabilities
N/A
59.51 M
N/A
N/A
N/A
247.9 M
512.96 M
12.83 M
17.42 M
N/A
Total Asset
1.74 B
2.68 B
2.46 B
623.3 M
1.56 B
4.96 B
2.43 B
122.44 M
430.96 M
1.83 B
Debt To Equity
0.35
0.56
1.28
0.37
0.29
0.69
0.18
0.37
0.64
0.19
Short Ratio
10.23
3.46
0.74
0.94
4.22
5.87
3.92
4.37
3.22
6.31
Target Price
28.88
25.55
10.0
42.4
14.28
15.48
15.0
N/A
16.5
5.28
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.48
N/A
N/A
Shares Owned By Institutions
96.18
96.06
99.7
51.59
95.94
86.91
97.3
52.08
91.6
94.76
Market Capitalization
8.93 B
1.53 B
1.37 B
6.91 M
1.76 B
6.04 B
669.76 M
458.72 M
133.71 M
540.65 M
Price To Earning
127.17
-13.88
148.7
N/A
N/A
75.0
3.87
26.72
29.85
N/A
Price To Earnings To Growth
-0.21
-1.37
0.15
N/A
0.49
2.06
2.42
3.42
0.88
1.03
Price To Sales
10.58
0.62
1.16
0.0028
4.72
2.45
0.44
3.18
0.39
2.11
Net Income
(130.4 K)
(113.04 M)
(19.43 M)
(683.35 M)
(55.36 M)
3.3 M
134.44 M
30.97 M
(798 K)
(202.39 M)
Earnings Per Share
0.43
-0.92
-0.14
-208.91
-0.2
-0.14
0.86
1.12
-0.06
-3.09
Shares Owned By Insiders
0.97
3.94
1.69
24.17
2.59
1.04
2.7
37.3
4.47
3.91
Revenue
805.5 M
1.96 B
1.17 B
751.1 M
354.34 M
2.25 B
1.5 B
148.58 M
336.79 M
251.41 M
Working Capital
N/A
9.43 M
141.13 M
(255.46 M)
210.18 M
287.1 M
214.26 M
(11.84 M)
30.1 M
223.25 M
Cash And Equivalents
439.4 M
188.2 M
28.92 M
68.13 M
195.44 M
134.8 M
500.16 M
32.97 M
15.11 M
347.87 M
Cash Per Share
2.48
1.57
0.22
0.78
1.22
0.32
4.51
1.33
1.05
3.46
Gross Profit
365.1 M
316.58 M
430.97 M
80.3 M
203.07 M
361.3 M
738.26 M
94.52 M
154.44 M
196.79 M
Day Typical Price
30.49
12.81
16.94
0.45
11.16
14.31
13.35
19.5
25.16
4.69
Accumulation Distribution
N/A
0.1
0.0336
227643.0
0.0302
0.0014
0.0141
2001.99
0.0244
8976.04
Market Facilitation Index
N/A
1.39
0.58
N/A
0.34
0.02
0.19
0.0
0.62
0.0
Daily Balance Of Power
0.0
(0.24)
0.3621
(1.07)
1.0
0.5
(0.11)
(0.08)
0.4839
(0.12)
Period Momentum Indicator
N/A
(0.33)
0.21
(0.15)
0.34
0.01
(0.02)
(0.06)
0.3
(0.02)
Rate Of Daily Change
1.0
0.98
1.01
0.74
1.03
1.0
1.0
1.0
1.01
1.0
Day Median Price
30.49
12.75
16.97
0.47
11.1
14.31
13.37
19.51
25.08
4.71
Price Action Indicator
N/A
0.02
0.025
(0.13)
0.34
0.005
(0.04)
(0.06)
0.4
(0.06)
Relative Strength Index
65.32
22.45
50.63
44.34
44.41
67.2
66.46
54.72
45.86
58.92
Coefficient Of Variation
812.4
(654.45)
10243.21
(495.93)
(1,078)
406.52
1467.97
(1,847)
(1,395)
3943.01
Mean Deviation
0.4676
3.24
2.06
6.54
1.95
0.1039
1.27
1.96
1.5
2.06
Jensen Alpha
0.0662
(1.18)
(0.06)
(2.15)
(0.51)
0.0221
0.0614
(0.36)
(0.20)
(0.16)
Total Risk Alpha
(0.04)
(2.08)
(0.39)
(3.70)
(0.70)
0.0024
(0.17)
(0.55)
(0.50)
(0.36)
Sortino Ratio
(0.06)
N/A
(0.04)
N/A
N/A
(0.61)
(0.01)
N/A
N/A
(0.03)
Downside Variance
0.221
N/A
8.61
N/A
N/A
0.025
5.28
N/A
N/A
6.52
Standard Deviation
0.8462
6.67
2.54
10.29
2.77
0.1397
1.74
2.57
2.13
2.62
Kurtosis
30.87
31.32
(0.52)
6.96
2.45
1.11
1.0
0.6938
8.72
(0.02)
Potential Upside
0.7674
5.49
4.03
12.64
5.82
0.2853
2.58
3.79
2.85
4.37
Treynor Ratio
0.4052
(0.83)
0.0236
(3.62)
(0.13)
1.29
0.277
(0.09)
(0.49)
0.0311
Maximum Drawdown
5.76
51.11
10.75
80.24
15.96
0.6415
8.73
13.17
14.25
13.2
Variance
0.716
44.46
6.47
105.8
7.69
0.0195
3.03
6.62
4.52
6.85
Market Risk Adjusted Performance
0.4152
(0.82)
0.0336
(3.61)
(0.12)
1.3
0.287
(0.08)
(0.48)
0.0411
Risk Adjusted Performance
0.0951
(0.11)
0.0145
(0.14)
(0.06)
0.1433
0.0577
(0.03)
(0.05)
0.0265
Skewness
4.67
(4.54)
(0.21)
(0.77)
0.903
0.4461
(0.79)
0.017
(1.93)
0.1578
Semi Deviation
0.211
N/A
2.87
N/A
N/A
0.0
2.08
N/A
N/A
2.42
Information Ratio
(0.03)
(0.17)
(0.04)
(0.21)
(0.14)
(0.69)
(0.01)
(0.10)
(0.13)
(0.02)
Value At Risk
(0.76)
(5.92)
(4.45)
(17.39)
(4.01)
(0.21)
(3.07)
(4.72)
(3.01)
(4.00)
Expected Short fall
(0.67)
N/A
(1.81)
N/A
N/A
(0.15)
(1.14)
N/A
N/A
(2.26)
Downside Deviation
0.4702
N/A
2.93
N/A
N/A
0.1582
2.3
N/A
N/A
2.55
Semi Variance
0.0445
N/A
8.26
N/A
N/A
(0.02)
4.31
N/A
N/A
5.88

Signify Health Competition Performance Charts

Five steps to successful analysis of Signify Health Competition

Signify Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Signify Health in relation to its competition. Signify Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Signify Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Signify Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Signify Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Signify Health position

In addition to having Signify Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Most Shorted Equities Thematic Idea Now

Most Shorted Equities
Most Shorted Equities Theme
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 243 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Signify Stock

If you are still planning to invest in Signify Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Signify Health's history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
CEOs Directory
Screen CEOs from public companies around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY